Receptor for AGE (RAGE) and its ligands-cast into leading roles in diabetes and the inflammatory response

Journal of Molecular Medicine

Volumn 87, Issue 3, 2009, Pages 235-247

  Yan, Shi Fang ^a   Ramasamy, Ravichandran ^a   Schmidt, Ann Marie ^a  

^a Columbia University ^*  (United States)

Author keywords

Complications; Diabetes; Glycation; Receptor

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; CALGRANULIN; GLUCOSE; HIGH MOBILITY GROUP B1 PROTEIN; LIGAND; PROTEIN S 100;

ADAPTIVE IMMUNITY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; GLYCATION; HUMAN; HYPERGLYCEMIA; INFLAMMATION; INNATE IMMUNITY; NONHUMAN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; DIABETES MELLITUS; GLYCOSYLATION END PRODUCTS, ADVANCED; HMGB1 PROTEIN; HUMANS; LEUKOCYTE L1 ANTIGEN COMPLEX; MODELS, BIOLOGICAL; RECEPTORS, IMMUNOLOGIC; S100 PROTEINS; SIGNAL TRANSDUCTION;

EID: 60549110804     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-009-0439-2     Document Type: Review

References (120)

1. AM Schmidt M Vianna M Gerlach 1992 Isolation and characterization of binding proteins for advanced glycosylation endproducts from lung tissue which are present on the endothelial cell surface J Biol Chem 267 14987 14997
2. R Ramasamy SJ Vannucci SS Yan 2005 Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation Glycobiol 15 16R 28R
3. MA Hofmann S Drury C Fu 1999 RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides Cell 97 889 901
4. O Hori J Brett T Slattery 1995 The receptor for advanced glycation endproducts (RAGE) is a cellular binding site for amphoterin: mediation of neurite outgrowth and co-expression of RAGE and amphoterin in the developing nervous system J Biol Chem 270 25752 25761
5. A Taguchi DC Blood G del Toro 2000 Blockade of amphoterin/RAGE signalling suppresses tumor growth and metastases Nature 405 354 360
6. SD Yan X Chen J Fu 1996 RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease Nature 382 685 691
7. SD Yan H Zhu A Zhu 2000 Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis Nat Med 6 643 651
8. T Chavakis A Bierhaus N Al-Fakhri 2003 The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment J Exp Med 198 1507 1515
9. J Brett AM Schmidt YS Zou 1993 Tissue distribution of the receptor for advanced glycation endproducts (RAGE): expression in smooth muscle, cardiac myocytes, and neural tissue in addition to the vasculature Am J Pathol 143 1699 1712
10. T Kislinger C Fu B Huber 1999 Ne (carboxymethyl)lysine modifications of proteins are ligands for RAGE that activate cell signalling pathways and modulate gene expression J Biol Chem 274 31740 31749
11. M Brownlee 1992 Nonenzymatic glycosylation of macromolecules. Prospects of pharmacologic modulation Diabetes 41 Suppl 2 57 60
12. E Harja DX Bu BI Hudson 2008 Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in Apo E-/- mice J Clin Invest 118 183 194
13. LG Bucciarelli R Ananthakrishnan YC Hwang 2008 RAGE and modulation of ischemic injury in the diabetic myocardium Diabetes 57 1941 1951
14. MP Wautier O Chappey S Corda 2001 Activation of NADPH oxidase by AGEs links oxidant stress to altered gene expression via RAGE Am J Physiol Endocrinol Metab 280 E685 E694
15. M Kalousova T Zima V Tesar 2005 Advanced glycoxidation end products in chronic diseases-clinical chemistry and genetic background Mut Res 579 37 46
16. M Witko-Sarsat T Nguyen-Khoa P Jungers 1999 Advanced oxidation protein products as novel molecular basis of oxidative stress in uremia Nephrol Dial Transplant 14 Suppl 1 76 78
17. AA Woods SM Linton MJ Davies 2003 Detection of HOCl-mediated protein oxidation products in the extracellular matrix of human atherosclerotic plaques Biochem J 370 729 735
18. H Kaneda J Taguchi K Ogasawara 2002 Increased level of advanced oxidation protein products in patients with coronary artery disease Atherosclerosis 162 221 225
19. PJ Thornalley 2007 Dietary AGEs and ALEs and risk to human health by their interaction with the receptor for advanced glycation endproducts (RAGE)-an introduction Mol Nutr Food Res 51 1107 1110
20. S Rahbar 2007 Novel inhibitors of glycation and AGE formation Cell Biochem Biophys 48 147 157
21. R Donato 2007 RAGE: a single receptor for several ligands and different cellular responses: the case of certain S100 proteins Curr Mol Med 7 711 724
22. S Ghavami I Rashedi BM Dattilo 2008 S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway J Leukoc Biol 83 1484 1492
23. O Turovskaya D Foell P Sinha 2008 RAGE, carboxylated glycans and S100A8/A9 play essential roles in colitis-associated carcinogenesis Carcinogenesis 29 2035 2043
24. MK Fuentes SS Nigavekar T Arumugam 2007 RAGE activation by S100P in colon cancer stimulates growth, migration and cell signaling pathways Dis Col Rectum 50 1230 1240
25. P Scaffidi T Misteli ME Bianchi 2002 Release of chromatin protein HMGB1 by necrotic cells triggers inflammation Nature 418 191 195
26. JE Ellerman CK Brown M de Vera 2007 Masquerader: high mobility group box-1 and cancer Clin Cancer Res 13 2836 2848
27. A Porto R Palumbo M Pieroni 2006 Smooth muscle cells in human atherosclerotic plaques secrete and proliferate in response to high mobility group box 1 protein FASEB J 20 2565 2566
28. K Inoue K Kawahara KK Biswas 2007 HMGB1 expression by activated vascular smooth muscle cells in advanced human atherosclerosis plaques Cardiovasc Pathol 16 136 143
29. N Kalinina A Agrotis Y Antropova 2004 Increased expression of the DNA-binding cytokine HMGB1 in human atherosclerotic lesions: role of activated macrophages and cytokines Arterioscler Thromb Vasc Biol 24 2320 2325
30. S Muhammad W Barakat S Stoyanov 2008 The HMGB1 receptor RAGE mediates ischemic brain damage J Neurosci 28 12023 12031
31. M Andrassy HC Volz JC Igwe 2008 High mobility group box-1 in ischemia-reperfusion injury of the heart Circ 117 3216 32226
32. O Arancio HP Zhang X Chen 2004 RAGE potentiates Abeta-induced perturbation of neuronal function in transgenic mice EMBO J 23 4096 4105
33. YM Li T Mitsuhashi D Wojciechowicz 1996 Molecular identity and cellular distribution of advanced glycation endproduct receptors: relationship of p60 to OST-48 and p90 to 80 K-H membrane proteins Proc Natl Acad Sci USA 93 11047 11052
34. N Ohgami R Nagai M Ikemoto 2002 CD36 serves a receptor for advanced glycation endproducts (AGEs) J Diabetes Complicat 16 56 59
35. S Horiuchi Y Sakamoto M Sakai 2003 Scavenging receptors for oxidized and glycated proteins Amino Acids 25 283 292
36. C Lu JC He W Cai 2004 Advanced glycation endproduct (AGE) receptor 1 is a negative regulator of the inflammatory response to AGE in mesangial cells Proc Natl Acad Sci USA 101 11767 11772
37. S McFarlane JV Glenn AM Lichanska 2005 Characterization of the advanced glycation endproduct receptor complex in the retinal pigment epithelium Br J Ophthalmol 89 107 112
38. J Tian AM Avalos SY Mao 2007 Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE Nat Immunol 8 487 496
39. M Yu H Wang A Ding 2006 HMGB1 signals through toll-like receptor (TLR) 4 and TLR2 Shock 26 174 179
40. TM Wendt N Tanji J Guo 2003 RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy Am J Pathol 162 1123 1137
41. T Miyata O Hori J Zhang 1996 The receptor for advanced glycation end products (RAGE) is a central mediator of the interaction of AGE-β2 microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway. Implications for the pathogenesis of dialysis-related amyloidosis J Clin Invest 98 1088 1094
42. M Andrassy J Igwe F Autschbach 2006 Posttranslationally modified proteins as mediators of sustained intestinal inflammation Am J Path 169 1223 1237
43. T Ostendorp E Leclerc A Galichet 2007 Structural and functional insights into RAGE activation by multimeric S100B EMBO J 26 3868 3878
44. J Xie DS Burz W He 2007 Hexameric calgranulin C (S100A12) binds to the receptor for advanced glycated end products (RAGE) using symmetric hydrophobic target-binding patches J Biol Chem 282 4218 4231
45. E Leclerc G Fritz M Weibel 2007 S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE immunoglobulin domains J Biol Chem 282 31317 31331
46. J Xie S Reverdatto A Frolov 2008 Structural basis for pattern recognition by the receptor for advanced glycation end products (RAGE) J Biol Chem 283 27255 27269
47. AP Burke FD Kolodgie A Zieske 2004 Morphologic findings of coronary atherosclerotic plaques in diabetics: a postmortem study Arterioscler Thromb Vasc Biol 24 1266 1271
48. H Yonekura S Sakurai RG Petrova 2003 Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury Biochem J 370 1097 1109
49. BI Hudson AM Carter E Harja 2008 Identification, classification, and expression of RAGE gene splice variants FASEB J 22 1572 1580
50. A Raucci S Cugusi A Antonelli 2008 A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10) FASEB J 22 3716 3727
51. C Falcone E Emanuele A D'Angelo 2005 Plasma levels of soluble receptor for advanced glycation endproducts and coronary artery disease in nondiabetic men Arterioscler Thromb Vasc Biol 25 1032 1037
52. N Katakami M Matsuhisa H Kaneto 2007 Serum endogenous secretory RAGE levels are inversely associated with carotid IMT in type 2 diabetic patients Atherosclerosis 190 22 23
53. H Koyama T Shoji S Fukumoto 2007 Low circulating endogenous secretory receptor for AGEs predicts cardiovascular mortality in patients with end-stage renal disease Arterioscler Thromb Vasc Biol 27 147 153
54. K Nakamura S Yamagishi H Adachi 2007 Serum levels of sRAGE, the soluble form of receptor for advanced glycation endproducts, are associated with inflammatory markers in patients with type 2 diabetes Mol Med 13 185 189
55. K Nakamura S Yamagishi H Adachi 2008 Serum levels of receptor for advanced glycation endproducts (sRAGE) are positively associated with circulating AGEs and soluble form of VCAM-1 in patients with type 2 diabetes Microvasc Res 76 52 56
56. Y Koyama Y Takeishi S Suzuki 2008 Soluble receptor for advanced glycation endproducts is a prognostic factor for heart failure J Card Fail 14 133 139
57. C Falcone I Campo E Emanuele 2005 -374T/A polymorphism of the RAGE gene promoter in relation to severity of coronary atherosclerosis Clin Chim Acta 354 111 116
58. C Falcone D Geroldi MP Buzzi 2008 The -374T/A RAGE polymorphism protects against future cardiac events in nondiabetic patients with coronary artery disease Arch Med Res 39 320 325
59. MA Hofmann Q Yang E Harja 2005 The RAGE Gly82Ser polymorphism is not associated with cardiovascular disease in the Framingham offspring study Atherosclerosis 182 301 305
60. L Park KG Raman KJ Lee 1998 Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts Nat Med 4 1025 1031
61. T Wendt E Harja L Bucciarelli 2006 RAGE modulates vascular inflammation and atherosclerosis in a murine model of type 2 diabetes Atherosclerosis 185 70 77
62. RK Vikramadithyan Y Hu HL Noh 2005 Human aldose reductase expression accelerates diabetic atherosclerosis in transgenic mice J Clin Invest 115 2434 2443
63. LG Bucciarelli T Wendt W Qu 2002 RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E null mice Circ 106 2827 2835
64. A Soro-Paavonen AM Watson J Li 2008 RAGE deficiency attenuates the development of atherosclerosis in diabetes Diabetes 57 2461 2469
65. T Higashi H Sano T Saishoji 1997 The receptor for advanced glycation end products mediates the chemotaxis of rabbit smooth muscle cells Diabetes 46 463 472
66. R Wang M Kudo M Yokoyama 2001 Roles of advanced glycation end products (AGE) and receptor for AGE on vascular smooth muscle cell growth J Nippon Med Scho 68 472 481
67. HM Lander JM Tauras JS Ogiste 1997 Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress J Biol Chem 272 17810 17814
68. MA Reddy SL Li S Sahar 2006 Key role of Src kinase in S100B-induced activation of the receptor for advanced glycation endproducts in vascular smooth muscle cells J Biol Chem 281 13685 13693
69. SS Shaw AM Schmidt AK Banes 2003 S100B-RAGE-mediated augmentation of angiotensin II-induced activation of Jak2 in vascular smooth muscle cells is dependent on PLD2 Diabetes 52 2381 2388
70. Z Zhou K Wang MS Penn 2003 Receptor for AGE (RAGE) mediates neointimal formation in response to arterial injury Circ 107 2238 2243
71. T Sakaguchi SF Yan SD Yan 2003 Arterial restenosis: central role of RAGE-dependent neointimal expansion J Clin Invest 111 959 972
72. K Wang Z Zhou M Zhang 2006 Peroxisome proliferator-activated receptor gamma down-regulates receptor for advanced glycation end products and inhibits smooth muscle cell proliferation in a diabetic and nondiabetic rat carotid artery injury model J Pharmacol Exp Ther 317 37 43
73. T Yoshida S Yamagishi K Makamura 2006 Telmisartan inhibits AGE-induced C-reactive protein production through downregulation of the receptor for AGE via peroxisome proliferators-activated receptor-gamma activation Diabetologia 49 3094 3099
74. JS Chang T Wendt W Qu 2008 Oxygen deprivation triggers upregulation of early growth response-1 by the receptor for advanced glycation endproducts Circ Res 102 905 913
75. N Tanji GS Markowitz C Fu 2000 The expression of advanced glycation endproducts and their cellular receptor RAGE in diabetic nephropathy and non-diabetic renal disease J Am Soc Nephrol 11 1656 1666
76. M Abel U Ritthaler Y Zhang 1995 Expression of receptors for advanced glycosylated end products in renal disease Nephrol Dial Transplant 19 1662 1667
77. FF Hou H Ren WF Owen Jr 2004 Enhanced expression of receptor for advanced glycation endproducts in chronic kidney disease J Am Soc Nephrol 15 1889 1896
78. D Suzuki M Toyoda N Yamamoto 2006 Relationship between the expression of advanced glycation endproducts (AGE) and the receptor for AGE (RAGE) mRNA in diabetic nephropathy Intern Med 45 435 441
79. M Kalousova M Hodkova M Kazderova 2006 Soluble receptor for advanced glycation endproducts in patients with decreased renal function Am J Kidney Dis 47 406 411
80. M Kalousova M Jachymova O Mestek 2007 Receptor for advanced glycation endproducts-soluble form and gene polymorphisms in chronic haemodialysis patients Nephrol Dial Transplant 22 2020 2026
81. E Lindholm E Bakhtadze M Sjogren 2006 The -374 T/A polymorphism in the gene encoding RAGE is associated with diabetic nephropathy and retinopathy in type 1 diabetic patients Diabetologia 49 2745 2755
82. G Prevost I Fajardy C Besmond 2005 Polymorphisms of the receptor of advanced glycation endproducts (RAGE) and the development of nephropathy in type 1 diabetic patients Diabetes Metabol 31 35 39
83. G Rudofsky Jr B Isermann T Schilling 2004 A 63 bp deletion in the promoter of RAGE correlates with a decreased risk for nephropathy in patients with type 2 diabetes Exp Clin Endocrinol Diabetes 112 135 141
84. S Matsunaga-Irie T Maruyama Y Yamamoto 2004 Relation between development of nephropathy and the p22phox C242T and receptor for advanced glycation end product G1704T gene polymorphisms in type 2 diabetic patients Diabetes Care 27 303 307
85. K Pettersson-Fernholm C Forsblom BI Hudson 2003 The functional -374T/A RAGE polymorphism is associated with proteinuria and cardiovascular disease in type 1 diabetic patients Diabetes 52 891 894
86. O Poirier V Nicaud N Vionnet 2001 Polymorphism screening of four genes encoding advanced glycation endproduct putative receptors. Association study with nephropathy in type 1 diabetic patients Diabetes 50 1214 1218
87. K Kankova A Stejskalova M Hertlova 2005 Haplotype analysis if the RAGE gene: identification of a haplotype marker for diabetic nephropathy in type 2 diabetes mellitus Nephrol Dial Transplant 20 1093 1102
88. JM Forbes SR Thorpe V Thallas-Bonke 2005 Modulation of soluble receptor for advanced glycation end products by angiotensin-converting enzyme-1 inhibition in diabetic nephropathy J Am Soc Nephrol 16 2363 2372
89. K Nakamura S Yamaghisi Y Nakamura 2005 Telmisartan inhibits expression of a receptor for advanced glycation end products (RAGE) in angiotensin II-exposed endothelial cells and decreases serum levels of soluble RAGE in patients with essential hypertension Microvasc Res 70 137 141
90. KM Myint Y Yamamoto T Doi 2006 RAGE control of diabetic nephropathy in a mouse model: effects of RAGE gene disruption and administration of low-molecular weight heparin Diabetes 55 2510 2522
91. LJ Jensen L Denner BF Schrijvers 2006 Renal effects of a neutralizing RAGE antibody in long-term streptozotocin-diabetic mice J Endocrinol 188 493 501
92. A Flyvbjerg L Denner BF Schrijvers 2004 Long-term effects of a neutralizing RAGE antibody in obese type 2 diabetic mice Diabetes 53 166 172
93. JM Bohlender S Franke G Stein 2005 Advanced glycation end products and the kidney Am J Physiol Renal Physiol 289 F645 F659
94. J Guo R Ananthakrishnan W Qu 2008 RAGE mediates podocyte injury in adriamycin-induced glomerulosclerosis J Am Soc Nephrol 19 961 972
95. L Gu S Hagiwara Q Fan 2006 Role of receptor for advanced glycation end-products and signalling events in advanced glycation end-product-induced monocyte chemoattractant protein-1 expression in differentiated mouse podocytes Nephrol Dial Transplant 21 299 313
96. MD Oldfield LA Bach JM Forbes 2001 Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via RAGE J Clin Invest 108 1853 1863
97. A Bierhaus KM Haslbeck PM Humpert 2004 Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily J Clin Invest 114 1741 1751
98. R Wada S Yagahiashi 2005 Role of advanced glycation end products and their receptors in development of diabetic neuropathy Ann NYAcad Sci 1043 598 604
99. U Del Carro P Fiorina S Amadio 2007 Evaluation of polyneuropathy markers in type 1 diabetic kidney transplant patients and effects of islet transplantation: neurophysiological and skin biopsy longitudinal analysis Diabetes Care 30 3063 3069
100. PM Humpert G Papadopoulos K Schaefer 2007 sRAGE and esRAGE are not associated with peripheral or autonomic neuropathy in type 2 diabetes Horm Metab Res 39 899 902
101. C Toth LL Rong C Yang 2008 Receptor for advanced glycation endproducts (RAGE) and experimental diabetic neuropathy Diabetes 57 1002 1017
102. LL Rong W Trojaborg W Qu 2004 Antagonism of RAGE suppresses peripheral nerve regeneration FASEB J 18 1812 1817
103. LL Rong SF Yan T Wendt 2004 RAGE modulates peripheral nerve regeneration via recruitment of both inflammatory and axonal outgrowth pathways FASEB J 18 1818 1825
104. L Wang S Li FB Jungalwala 2008 Receptor for advanced glycation end products (RAGE) mediates neuronal differentiation and neurite outgrowth J Neurosci Res 86 1254 1266
105. KS Collison RS Parhar SS Saleh 2002 RAGE-mediated neutrophil dysfunction is evoked by advanced glycation endproducts (AGEs) J Leukoc Biol 71 433 444
106. AM Schmidt SD Yan J Brett 1993 Regulation of human mononuclear phagocyte migration by cell surface-binding proteins for advanced glycation end products J Clin Invest 91 2155 2168
107. Y Chen SS Yan J Colgan 2004 Blockade of the late stages of autoimmune diabetes by inhibition of the receptor for advanced glycation endproducts J Immunol 173 1399 1405
108. G Cataldegirmen S Zeng N Feirt 2005 RAGE limits regeneration after massive liver injury by coordinated suppression of TNF-alpha and NF-kappaB J Exp Med 201 473 484
109. D Foell M Frosch C Sorg 2004 Phagocyte-specific calcium-binding S100 proteins as clinical laboratory markers of inflammation Clin Chim Acta 344 37 51
110. A Kosaki T Hasegawa T Kimura 2004 Increased plasma S100A12 (EN-RAGE) levels in patients with type 2 diabetes J Clin Endocrinol Metab 89 5423 5428
111. T Hatada H Wada T Nobori 2005 Plasma concentrations and importance of high mobility group box protein in the prognosis of organ failure in patients with disseminated intravascular coagulation Thromb Haemost 94 975 979
112. MA Hofmann S Drury BI Hudson 2002 RAGE and arthritis. The G82S polymorphism amplifies the inflammatory response Genes Immun 3 123 135
113. B Moser MJ Szabolcs HJ Ankersmit 2007 Blockade of RAGE suppresses alloimmune reactions in vitro and delays allograft rejection in heart transplantation Am J Transplant 7 293 302
114. SSD Yan ZY Wu HP Zhang 2003 Suppression of experimental autoimmune encephalomyelitis by selective blockade of encephalitogenic T-cell infiltration of the central nervous system Nat Med 9 287 293
115. Y Chen EM Akirav W Chen 2008 RAGE ligation affects T cell activation and controls T cell differentiation J Immunol 181 4272 4278
116. B Moser DD Desai MP Downie 2007 Receptor for advanced glycation end products expression on T cells contributes to antigen-specific cellular expansion in vivo J Immunol 179 8051 8058
117. E Diamanti-Kandarakis C Piperi E Patsouris 2007 Immunohistochemical localization of advanced glycation endproducts (AGEs) and their receptor (RAGE) in polycystic and normal ovaries Histochem Cell Biol 127 581 589
118. E Diamanti-Kandarakis I Katsikis C Piperi 2008 Increased serum advanced glycation end products is a distinct finding in lean women with polycystic ovary syndrome (PCOS) Clin Endocrinol (Oxf) 69 634 641
119. B Liliensiek MA Weigand A Bierhaus 2004 Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response J Clin Invest 113 1641 1650
120. EC Lutterloh SM Opal DD Pittman 2007 Inhibition of the RAGE products increases survival in experimental models of severe sepsis and systemic infection Crit Care 11 R122